BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1917438)

  • 1. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: I. Similarities to Staphylococcus aureus Cowan Strain I (SAC) in the in vitro T-dependent antibody response.
    Morris DL; Jordan SD; Holsapple MP
    Immunopharmacology; 1991; 21(3):159-69. PubMed ID: 1917438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: II. B cell activation.
    Morris DL; Holsapple MP
    Immunopharmacology; 1991; 21(3):171-81. PubMed ID: 1917439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
    Snyder NK; Kramer CM; Dooley RK; Holsapple MP
    Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyte.
    Dooley RK; Holsapple MP
    Immunopharmacology; 1988; 16(3):167-80. PubMed ID: 3267010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression.
    Kerkvliet NI; Steppan LB; Brauner JA; Deyo JA; Henderson MC; Tomar RS; Buhler DR
    Toxicol Appl Pharmacol; 1990 Aug; 105(1):26-36. PubMed ID: 2168100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
    Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Karras JG; Holsapple MP
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: II. The role of the T-lymphocyte.
    Dooley RK; Morris DL; Holsapple MP
    Immunopharmacology; 1990; 19(1):47-58. PubMed ID: 2307581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells.
    Camacho IA; Nagarkatti M; Nagarkatti PS
    Arch Toxicol; 2002 Oct; 76(10):570-80. PubMed ID: 12373453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superantigen-primed T cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) replicate poorly following recall encounter.
    Faulconer L; Camacho I; Nagarkatti M; Nagarkatti PS
    Arch Toxicol; 2006 Mar; 80(3):134-45. PubMed ID: 16189661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of 2,2',4,4',5,5'-hexachlorobiphenyl and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antibody response to sheep erythrocytes in mice.
    Smialowicz RJ; DeVito MJ; Riddle MM; Williams WC; Birnbaum LS
    Fundam Appl Toxicol; 1997 Jun; 37(2):141-9. PubMed ID: 9242587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: differences between mice and rats.
    Smialowicz RJ; Riddle MM; Williams WC; Diliberto JJ
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):248-56. PubMed ID: 8122270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on humoral and cell-mediated immunity in Sprague-Dawley rats.
    Fan F; Wierda D; Rozman KK
    Toxicology; 1996 Jan; 106(1-3):221-8. PubMed ID: 8571394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCDD-mediated suppression of the in vitro anti-sheep erythrocyte IgM antibody forming cell response is reversed by interferon-gamma.
    North CM; Kim BS; Snyder N; Crawford RB; Holsapple MP; Kaminski NE
    Toxicol Sci; 2009 Jan; 107(1):85-92. PubMed ID: 18948302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the T cell-independent antibody response of mice and rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Smialowicz RJ; Williams WC; Riddle MM
    Fundam Appl Toxicol; 1996 Aug; 32(2):293-7. PubMed ID: 8921333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
    Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
    J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the high-affinity antibody response in C57BL/6 mice.
    Inouye K; Ito T; Fujimaki H; Takahashi Y; Takemori T; Pan X; Tohyama C; Nohara K
    Toxicol Sci; 2003 Aug; 74(2):315-24. PubMed ID: 12773764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
    North CM; Crawford RB; Lu H; Kaminski NE
    Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
    Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
    Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of TCDD-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice.
    Ito T; Inouye K; Fujimaki H; Tohyama C; Nohara K
    Toxicol Sci; 2002 Nov; 70(1):46-54. PubMed ID: 12388834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.